Results 221 to 230 of about 66,921 (262)
Some of the next articles are maybe not open access.

Mycobacteria: An Overview

Clinical Infectious Diseases, 1981
This International Conference on Atypical Mycobacteria, a gathering of outstanding scientists of many fields, attests to the biologic and clinical importance of the mycobacteria and mycobacterioses. This conference may help provide a basis for the formulation of cooperative projects for the attainment of knowledge in each of several fields where I ...
openaire   +2 more sources

Nontuberculous Mycobacteria

Seminars in Respiratory and Critical Care Medicine, 2021
AbstractNontuberculous mycobacteria (NTM) are ubiquitous in the environment and 193 species of NTM have been discovered thus far. NTM species vary in virulence from benign environmental organisms to difficult-to-treat human pathogens. Pulmonary infections remain the most common manifestation of NTM disease in humans and bronchiectasis continues to be a
Shera, Tan, Shannon, Kasperbauer
openaire   +2 more sources

ATYPICAL MYCOBACTERIA

2001
The nontuberculous mycobacteria are species different from Mycobacterium tuberculosis. In the past these organisms were referred to as “atypical” (as they were thought to be unusual M. tuberculosis strains), as “anonymous”, as “tuberculoid”, or as “opportunistic”, but actually they are widely known as environmental mycobacteria because their peculiar ...
Prignano F., Fabroni C., Lotti T.
openaire   +1 more source

Nontuberculous mycobacteria

2008
This chapter focuses on nontuberculous mycobacteria (NTM), organisms that are ubiquitous in the environment and are thus referred as “environmental mycobacteria” by some experts. Mycobacterium avium complex (MAC), which includes M. kansasii, M. fortuitum, and M. abscessus, is the most common NTM associated with human disease in the United States.
Timothy Aksamit, David E. Griffith
openaire   +1 more source

HIV and mycobacteria

Seminars in Diagnostic Pathology, 2017
The importance of mycobacteria as opportunistic pathogens, particularly members of the M. avium complex (MAC), in patients with progressive HIV infection was recognized early in the AIDS epidemic. It took longer to appreciate the global impact and devastation that would result from the deadly synergy that exists between HIV and M. tuberculosis.
openaire   +2 more sources

Electroporation of Mycobacteria

2015
High-efficiency transformation of DNA is integral to the study of mycobacteria, allowing genetic manipulation. Electroporation is the most widely used method for introducing DNA into mycobacterial strains. Many parameters contribute to high-efficiency transformation; these include the species per strain, the transforming DNA, the selectable marker, the
Goude, Renan   +2 more
openaire   +2 more sources

Mycobacteria and autoimmunity

Lupus, 2015
Mycobacterial infections can cause a variety of different manifestations. The increasing incidence of these infections worldwide brought another medical dilemma: immunological manifestations characterized by the presence of many autoantibodies and concomitant presence of autoimmune diseases.
F, Machado Ribeiro, T, Goldenberg
openaire   +2 more sources

Nontuberculous mycobacteria

Current Opinion in Pulmonary Medicine, 1997
The nontuberculous mycobacteria (NTM), especially Mycobacterium avium complex, are being recognized with increasing frequency as clinical pathogens, not only as a cause of disseminated disease in patients with AIDS but also as a cause of chronic lung disease in patients without AIDS. These infections have traditionally been difficult and frustrating to
openaire   +2 more sources

Atypical Mycobacteria

Pediatric Annals, 1978
The atypical mycobacteria are common human saprophytes. Their presence, particularly in a healthy person, is not associated with disease. In the child they cause two conditions, cervical adenitis and swimming-pool granuloma. Both of these diseases tend to be localized and nonprogressive. The former can be treated with reasonably nontoxic drugs; if this
openaire   +4 more sources

Immunity to mycobacteria

Current Opinion in Immunology, 1993
Recent progress in the field of immunity to mycobacteria has centered on T cell subset responses and the cytokines these cells secrete. In addition, there has been steady progress in identifying and characterizing several classes of major mycobacterial proteins; included amongst these are the secreted/export proteins of Mycobacterium tuberculosis ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy